Nocturne Acquisition Corp - Unit

Nocturne Acquisition Corp. is a blank check formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 28, 2020 and is headquartered in Wilmington, DE.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nocturne Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 28, 2020 and is headquartered in Wilmington, DE.

SANTA ANA, CA / ACCESSWIRE / April 17, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that it will be unable to complete an initial business combination with Cognos Therapeutics, Inc. and intends to liquidate the Trust Account. In connection with the liquidation of the Trust Account, the Company will redeem all of the outstanding public shares of common stock (the "Public Shares") at a per-share redemption price of approximately $11.79, after taking into account the removal of a portion of the accrued interest in the Trust Account to pay taxes and dissolution expenses.

Nocturne Acquisition Corporation Announces Termination and Liquidation of Trust Account

SANTA ANA, CA / ACCESSWIRE / March 19, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that the Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting that was to be held on March 19, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. ("Cognos"). The Extraordinary General Meeting will now be held virtually on April 2, 2024 at 9:00 a.m.

Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting Date

SANTA ANA, CA / ACCESSWIRE / February 5, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that the Board of Directors has voted in favor of a second postponement of the meeting date for the Extraordinary General Meeting that was to be held on January 30, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. The Extraordinary General Meeting that was postponed until February 6, 2024 has been postponed further and will now be held virtually on February 27, 2024 at 9:00 a.m. Eastern Time.

Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting

Nocturne Acquisition Corp

Transaction Expected to Accelerate the Research and Advancement of Cognos' Proprietary and Innovative Implantable Drug Delivery Pump to Improve Outcomes for Treatment of Brain Cancers and Other Neurological Diseases WILMINGTON, DE / ACCESSWIRE / August 16, 2023 / Nocturne Acquisition Corporation (NASDAQ:MBTC)(NASDAQ:MBTCU)(NASDAQ:MBTCR) (the "Company", "MBTC" or "Nocturne"), today announced the submission via Edgar, the U.S. Securities and Exchange Commission's ("SEC") online portal, for filing of a registration statement on Form S-4 (the "Registration Statement") with the SEC, which includes a preliminary proxy statement/prospectus in connection with the proposed business combination (the "Business Combination") with Cognos Therapeutics, Inc. ("Cognos"), a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and degenerative neurological conditions (such as Alzheimer's and Parkinson's disease), epilepsy, and stroke. The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previously announced Business Combination between Nocturne and Cognos.

Nocturne Acquisition Corporation Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Cognos

Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and degenerative neurological conditions (such as Alzheimer's and Parkinson's disease), epilepsy, and stroke. Cognos' lead product candidate is the SINNAISTM Implantable Smart Pump, believed to be the world's first implantable device under development for the metronomic delivery of therapeutics for neurological diseases, including brain cancer.

Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation

WILMINGTON, DE / ACCESSWIRE / July 5, 2022 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that an aggregate of $1,150,000 (the "Extension Payment") has been deposited into the Company's trust account for its public shareholders, representing $0.10 per public share, which enables the Company to extend the period of time it has to consummate its initial business combination by three months from July 5, 2022 to October 5, 2022 (the "Extension"). About Nocturne Acquisition Corp. The Company is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities.

Nocturne Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

LA JOLLA, CA / ACCESSWIRE / June 4, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU) (the "Company") today announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1).

Nocturne Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

LA JOLLA, CA / ACCESSWIRE / April 29, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU) (the "Company" or "MBTC") announced that, commencing May 3, 2021, holders of the units sold in the Company's initial public offering of 11,500,000 units, may elect to separately trade shares of the Company's ordinary shares and rights included in the units. The ordinary shares and rights that are separated will trade on the Nasdaq Capital Market under the symbols "MBTC" and "MBTCR," respectively.

Nocturne Acquisition Corporation Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 3, 2021

LA JOLLA, CA / ACCESSWIRE / April 14, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU), the "Company") announced today that the underwriters in its initial public offering, pursuant to the terms of the underwriting agreement, fully exercised their over-allotment option and, on April 14, 2021, closed the purchase of an additional 1,500,000 units in connection with its initial public offering at $10.00 per unit, generating additional gross proceeds of $15,000,000 and bringing the total gross proceeds of the initial public offering to $115,000,000. Each unit consists of one ordinary share and one right to receive one-tenth of one ordinary share upon the consummation of an initial business combination.

Nocturne Acquisition Corporation Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering

LA JOLLA, CA / ACCESSWIRE / April 5 , 2021 / Nocturne Acquisition Corporation (the "Company"), a special purpose acquisition company, today announced the closing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units began trading on The Nasdaq Capital Market ("Nasdaq") on March 31, 2021, under the ticker symbol "MBTCU".

Nocturne Acquisition Corporation Announces Closing of $100 Million Initial Public Offering

LA JOLLA, CA / ACCESSWIRE / March 31 , 2021 / Nocturne Acquisition Corporation (the "Company"), a special purpose acquisition company, today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market ("Nasdaq") and will begin trading on March 31, 2021, under the ticker symbol "MBTCU".

Nocturne Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering

News for Nocturne Acquisition Corp - Unit Stock (MBTCU)